摘要
目的:建立细胞内外博莱霉素-A2的HPLC含量测定方法,用于博莱霉素水解酶对博莱霉素代谢在细胞培养中的研究。方法:细胞培养液经过蛋白沉淀和细胞超声破壁预处理后,采用ZORBAX Eclipse plus C18(4.6mm×250mm,5μm)柱,流动相为甲醇-乙腈-pH4.2的0.05mmol·L^-1醋酸铵(7:7:86),流速1mL·min^-1,检测波长254nm。结果:研究结果表明培养液中博莱霉素-A2进样量在0.1~1.2μg范围内线性关系良好(r=0.9994,n=5),高、中、低3个浓度的平均回收率分别为102.2%(RSD=2.8%)、101.3%(RSD=1.5%)、99.8%(RSD=2.2%);细胞内液中博莱霉素一~进样量在0.02。0.8μg范围内线性关系良好(r=0.9998,n=5),高、中、低3个浓度的平均回收率分别为100.2%(RSD=1.2%)、99.6%(RSD=1.3%)、101.3%(RSD=1.1%)。样品溶液在24h内稳定性良好,博莱霉素-A2在培养液中的峰面积的RSD=2.8%,在细胞内液中的峰面积的RSD=1.5%。结论:该方法测定结果准确可靠,适用于博莱霉素~A2细胞培养中细胞内外的含量测定。
Objective: To establish an HPLC method for content determination of bleomycin - A2in cells so as to study the effect of hydrolase for bleomycin on the metabolism of bleomycin in cell culture. Methods: The cell cul- ture fluid was treated by protein precipitation and cell uhrasonification, and analyzed by HPLC under following con- ditions : a ZORBAX Eclipse C18 (4. 6 mmx 250 mm,5 p,m) was adopted using a mobile phase of methanol -aceto- nitrle -pH 4.2,0. 05 mmol · L^-1 ammonium acetate (7: 7: 86). The flow rate was 1.0 mL ~ min-1 and the detec- tion wavelength was 254 nm. Results: The results showed that the bleomycin -A2 had a good linearity in the con- centration range of 0. 1 - 1.2 p,g ( r = 0. 9994, n = 5 ). The average recoveries were 102. 2% ( RSD = 2. 8% ), 101.3% (RSD = 1.5% ) ,99.8% (RSD = 2. 2% ) for bleomycin - A2 at high, medium and low concentrations. In intracellular fluid ,the bleomycin A2had a good linearity in the concentration range of 0. 02-0. 8 p,g (r =0. 9998, n = 5 ). The average recoveries were 100. 2% ( RSD = 1.2% ) ,99.6% ( RSD = 1.3 % ) , 101.3 % ( RSD = 1.1% ) for bleomycin - A2 at high, medium and low concentrations. In addition, bleomycin - A2 was stable for at least 24 h in both the cell culture fluid ( RSD = 2. 8% ) and the intracellular fluid ( RSD = 1.5% ). Conclusion: A reliable HPLC method was established to measure the content of bleomycin - A2 in intracellular and extracellular culture.
出处
《药物分析杂志》
CAS
CSCD
北大核心
2014年第4期577-580,共4页
Chinese Journal of Pharmaceutical Analysis
基金
国家自然科学基金(81273553)
国家"重大新药创制专项"大平台项目(2012ZX09301002-001)